Literature DB >> 20623212

Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 2--investigation of bias in extra-fine mass fraction with AIM-HRT impactor.

Jolyon P Mitchell1, Mark W Nagel, Cathy C Doyle, Rubina S Ali, Valentina I Avvakoumova, J David Christopher, Jorge Quiroz, Helen Strickland, Terrence Tougas, Svetlana Lyapustina.   

Abstract

The purpose of this study was to resolve an anomalously high measure of extra-fine particle fraction (EPF) determined by the abbreviated cascade impactor possibly relevant for human respiratory tract (AIM-HRT) in the experiment described in Part 1 of this two-part series, in which the relative precision of abbreviated impactors was evaluated in comparison with a full resolution Andersen eight-stage cascade impactor (ACI). Evidence that the surface coating used to mitigate particle bounce was laterally displaced by the flow emerging from the jets of the lower stage was apparent upon microscopic examination of the associated collection plate of the AIM-HRT impactor whose cut point size defines EPF. A filter soaked in surfactant was floated on top of this collection plate, and further measurements were made using the same pressurized metered-dose inhaler-based formulation and following the same procedure as in Part 1. Measures of EPF, fine particle, and coarse particle fractions were comparable with those obtained with the ACI, indicating that the cause of the bias had been identified and removed. When working with abbreviated impactors, this precaution is advised whenever there is evidence that surface coating displacement has occurred, a task that can be readily accomplished by microscopic inspection of all collection plates after allowing the impactor to sample ambient air for a few minutes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623212      PMCID: PMC2974126          DOI: 10.1208/s12249-010-9473-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  The role of inertial particle collectors in evaluating pharmaceutical aerosol delivery systems.

Authors:  V A Marple; B A Olson; N C Miller
Journal:  J Aerosol Med       Date:  1998

2.  Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree.

Authors:  Dave Christopher; Paul Curry; Bill Doub; Kenneth Furnkranz; Martin Lavery; Karl Lin; Svetlana Lyapustina; Jolyon Mitchell; Brian Rogers; Helen Strickland; Terrence Tougas; Yi Tsong; Bruce Wyka
Journal:  J Aerosol Med       Date:  2003

3.  Evaluation of preseparator performance for the 8-stage nonviable andersen impactor.

Authors:  V V Sethuraman; A J Hickey
Journal:  AAPS PharmSciTech       Date:  2001-03-26       Impact factor: 3.246

Review 4.  Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.

Authors:  Jolyon P Mitchell; Mark W Nagel
Journal:  J Aerosol Med       Date:  2003

Review 5.  Measurement of particle size characteristics of metered dose inhaler (MDI) aerosols.

Authors:  M Dolovich
Journal:  J Aerosol Med       Date:  1991

6.  Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 1.

Authors:  Jolyon P Mitchell; Mark W Nagel; Cathy C Doyle; Rubina S Ali; Valentina I Avvakoumova; J David Christopher; Jorge Quiroz; Helen Strickland; Terrence Tougas; Svetlana Lyapustina
Journal:  AAPS PharmSciTech       Date:  2010-05-18       Impact factor: 3.246

7.  Reducing bounce effects in the Andersen cascade impactor.

Authors:  Craig Dunbar; Abdo Kataya; Tiba Tiangbe
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

8.  The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.

Authors:  J P Mitchell; M W Nagel; V Avvakoumova; H MacKay; R Ali
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

  8 in total
  3 in total

1.  Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).

Authors:  Changning Guo; Diem Ngo; Shafiq Ahadi; William H Doub
Journal:  AAPS PharmSciTech       Date:  2013-06-19       Impact factor: 3.246

2.  Product lifecycle approach to cascade impaction measurements.

Authors:  Terrence P Tougas; Dave Christopher; Jolyon Mitchell; Svetlana Lyapustina; Michiel Van Oort; Richard Bauer; Volker Glaab
Journal:  AAPS PharmSciTech       Date:  2011-02-01       Impact factor: 3.246

3.  Good Cascade Impactor Practice (GCIP) and considerations for "in-use" specifications.

Authors:  S C Nichols; J P Mitchell; C M Shelton; D L Roberts
Journal:  AAPS PharmSciTech       Date:  2013-01-24       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.